<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To determine the cardiological substrate in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients presenting with a cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> subtype </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Data of 402 consecutive patients with cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> (<z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, n=347; <z:e sem="disease" ids="C0007787" disease_type="Disease or Syndrome" abbrv="tia|TIA|T.I.A.">transient ischaemic attack</z:e>, n=55) were collected from a prospective hospital-based <z:hpo ids='HP_0001297'>stroke</z:hpo> registry in which data on 2000 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients over a 10-year period were included </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, specific <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disorders</z:e> were identified by physical examination and results of electrocardiography and transthoracic echocardiography </plain></SENT>
<SENT sid="3" pm="."><plain>Holter monitoring and more sensitive techniques of cardiac imaging were used in selected cases </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Cardioembolic <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> accounted for 20% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>strokes</z:hpo> (25% of ischaemic cerebrovascular events) </plain></SENT>
<SENT sid="5" pm="."><plain>Cardiac sources of embolism included the following: (a) structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disorders</z:e> associated with <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> (n=232), the most frequent being left ventricular hypertrophic <z:e sem="disease" ids="C0020538" disease_type="Disease or Syndrome" abbrv="HTN">hypertensive disease</z:e> (n=120) and <z:e sem="disease" ids="C0264765" disease_type="Disease or Syndrome" abbrv="">rheumatic mitral valve disease</z:e> (n=49); (b) structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> with sustained sinus rhythm (n=81), the most frequent being systolic left ventricular dysfunction of both ischaemic (n=35) or non-ischaemic (n=24) aetiology; and (c) isolated atrial dysrhythmia (<z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, n=88 and <z:hpo ids='HP_0004749'>atrial flutter</z:hpo>, n=1) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Hypertrophic hypertensive <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> complicated with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> was the most frequent cardiac source of emboli in cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Other important cardiac sources were isolated <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, <z:e sem="disease" ids="C0264765" disease_type="Disease or Syndrome" abbrv="">rheumatic mitral valve disease</z:e>, and systolic left ventricular dysfunction of ischaemic and non-ischaemic cause </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of traditional emboligenous-prone <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disorders</z:e>, such as <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and mitral annular calcification was low </plain></SENT>
</text></document>